Shanghai Fosun Pharmaceutical Group, a Shanghai-listed pharmaceutical company controlled by Chinese billionaire Guo Guangchang, has added to its stake in U.S.-listed Simcere, a China-based drug manufacturer. Shanghai Fosun Pharmaceutical said in a statement at the Shanghai Stock Exchange today that a wholly owned subsidiary had raised its holding in Simcere to 4 million American depositary ...
FEEDS
